Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3 signaling
The mechanistic and preclinical evidence sits with the individual peptides chiefly GHK-Cu, which has the deepest literature while the specific three-peptide combination is used in research settings without combination-level trial data
Designed to balance glucose levels, promote weight management, and enhance energy, GLP-1 Boost provides comprehensive metabolic support
These incretin effects improve insulin secretion, reduce appetite, slow gastric emptying, and support glucose control
Your doctor smiles, says everything looks great, and sends you on your way